Inventor
DUNHAM SARAH
US17 patents
⚠️ This page may combine multiple inventors who share the name “DUNHAM SARAH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THERAVANCE INC
12 patentsUS7345060B2Mar 18, 2008
Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
THERAVANCE INC63 citations98
US7141671B2Nov 28, 2006
Biphenyl derivatives
THERAVANCE INC145 citations98
US7879879B2Feb 1, 2011
Biphenyl derivatives
THERAVANCE INC19 citations92
US7728144B2Jun 1, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC20 citations92
US7285564B2Oct 23, 2007
Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds
THERAVANCE INC10 citations84
US7842704B2Nov 30, 2010
Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
THERAVANCE INC5 citations74
US7838535B2Nov 23, 2010
Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
THERAVANCE INC5 citations74
US7368463B2May 6, 2008
Substituted 4-amino-1-benzylpiperidine compounds
THERAVANCE INC7 citations74
US7071224B2Jul 4, 2006
Diphenylmethyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC9 citations74
US8013152B2Sep 6, 2011
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC3 citations62
US7208515B2Apr 24, 2007
Diphenylmethyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC0 citations52
US7151115B2Dec 19, 2006
Diphenylmethyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC1 citations52
MAMMEN MATHAI
3 patentsUS8618131B2Dec 31, 2013
Biphenyl derivatives
MAMMEN MATHAI3 citations74
US8247564B2Aug 21, 2012
Compounds having BETA2 adrenergic receptor agonist and muscarinic receptor antagonist activity
MAMMEN MATHAI3 citations62
US8080565B2Dec 20, 2011
Substituted 4-amino-benzylpiperidine compounds
MAMMEN MATHAI0 citations52